Company intelligence / Profile preview

Xoft Solutions

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

The Axxent eBx system is FDA-cleared and CE marked, in use at over 120 sites in 16 countries for early-stage breast, skin, gynecological, and brain cancers, with emerging data for other indications. Published clinical results support safety, convenience (single-session IORT), and efficacy comparable to traditional approaches, especially for early-stage breast cancer and nonmelanomatous cutaneous malignancies.

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Xoft Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xoft Solutions.

Explore the full profile